Selected
MD&A
Consolidated Statements
Notes
Report of Independant Accountants
Supplementary Schedule

 

15 Financial Instruments with Off-Balance Sheet Risk and Concentrations of Credit Risk
As a market maker of OTC and listed stocks, the majority of the Company's securities transactions are conducted as principal with broker-dealer and institutional counterparties primarily located in the United States. The Company clears all of its securities transactions through clearing brokers on a fully disclosed basis. Pursuant to the terms of the agreement between the Company and the clearing brokers, the clearing brokers have the right to charge the Company for losses that result from a counterparty's failure to fulfill its contractual obligations. The Company's policy is to monitor the credit standing of the clearing brokers and all counterparties with which it conducts business. Additionally, as of December 31, 1999, the Company's credit exposures were concentrated with the clearing brokers and amounted to $193.5 million. As of December 31, 1999, the clearing brokers also held, as custodians, securities owned by the Company with a market value of $136 million.

The net receivable (payable) for securities transactions that have not reached their contractual settlement date amounted to $49,493,896 and $(5,126,772) at December 31, 1999 and 1998, respectively. Such amounts are included within receivable from clearing brokers on the Consolidated Statements of Financial Condition.

Securities sold, not yet purchased represent obligations to purchase such securities at a future date. The Company may incur a loss if the market value of the securities subsequently increases.